Product Information
FENTANYL 50 MCG/HR PATCH is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $9.0700 per EA under NDC 00378912298. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jan 28, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 ug/h
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378912298
Classification
Generic
Dosage Form
PATCH
Route
TRANSDERMAL
Effective Date
9/23/2026
Active Ingredients
FENTANYLApproval Type
Generic (ANDA)
FDA Application
ANDA076258FDA Approved
1/28/2005
TE Code
AB
On Market Since
1/31/2005
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL 50 MCG/HR PATCH has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 24.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0700 per EA |
|---|---|
| All-time high | $11.3007 (Mar 13, 2024) |
| All-time low | $4.2575 (Apr 17, 2019) |
| 52-week high | $9.7186 |
| 52-week low | $9.0700 |
| Median price | $6.0786 |
| Average price | $6.8066 |
| Largest weekly change | +24.8% (Jun 19, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FENTANYL market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENTANYL 50 MCG/HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL 50 MCG/HR PATCH, manufactured by Mylan Pharmaceuticals Inc., is $9.0700 per EA (NDC 00378912298), effective Sep 30, 2026.
How has the price of FENTANYL 50 MCG/HR PATCH changed over time?
Over the history we have for it, the NADAC for FENTANYL 50 MCG/HR PATCH has risen 24.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FENTANYL 50 MCG/HR PATCH?
Since Nov 28, 2013, the NADAC for FENTANYL 50 MCG/HR PATCH has ranged from a low of $4.2575 (Apr 17, 2019) to a high of $11.3007 (Mar 13, 2024), with a median of $6.0786 per EA.
Are there cheaper alternatives to FENTANYL 50 MCG/HR PATCH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FENTANYL 50 MCG/HR PATCH, is $8.4477 per EA — about 7% below FENTANYL 50 MCG/HR PATCH.
Who manufactures FENTANYL 50 MCG/HR PATCH?
FENTANYL 50 MCG/HR PATCH (NDC 00378912298) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.